Bank Julius Baer & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $169K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $497K | Sell |
|
|||||
|
2023
Q4 | $2.35M | Buy |
|
|||||
|
2023
Q3 | $1.25M | Buy |
|
|||||
|
2023
Q2 | $433K | Sell |
|
|||||
|
2023
Q1 | $702K | Sell |
|
|||||
|
2022
Q4 | $997K | Sell |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | $587K | Sell |
|
|||||
|
2022
Q1 | $585K | Buy |
|
|||||
|
2021
Q4 | $478K | Sell |
|
|||||
|
2021
Q3 | $584K | Sell |
|
|||||
|
2021
Q2 | $768K | Buy |
|
|||||
|
2021
Q1 | $548K | Sell |
|
|||||
|
2020
Q4 | $1.23M | Buy |
|
|||||
|
2020
Q3 | $55K | Buy |
|
|||||
|
2020
Q2 | $828K | Buy |
|
|||||
|
2020
Q1 | $379K | Buy |
|